CHMP is positive on Chiesi's Nymusa
This article was originally published in Scrip
Executive Summary
The EU's CHMP has recommended Chiesi's Nymusa (caffeine citrate 60mg/ml solution for infusion and oral solution) for marketing approval in the orphan indication of treating primary apnoea in premature newborns.